Company Search:
Advanced Search
Sponsored Links
CSPC Pharmaceutical Group Ltd - ADR Company Snapshot
CSPC Pharmaceutical Group Ltd - ADR operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares CSPC Pharmaceutical Group Ltd - ADR with three other companies in this sector in the United States: Ipsen SA (2016 sales of $1.84 billion of which 76% was Specialty Care), Vertex Pharmaceuticals Inc ($1.70 billion of which 100% was Pharmaceuticals), and United Therapeutics Corporation ($1.60 billion of which 100% was Pharmaceutical).

Sales Analysis. CSPC Pharmaceutical Group Ltd - ADR reported sales of $1.59 billion for the year ending December of 2016. This represents an increase of 8.4% versus 2015, when the company's sales were $1.47 billion. This was the fourth straight year of sales growth at CSPC Pharmaceutical Group Ltd - ADR. Sales of Finished Drugs saw an increase of 14.9% in 2016, from $1.01 billion to $1.16 billion. Not all segments of CSPC Pharmaceutical Group Ltd - ADR experienced an increase in sales in 2016: sales of Antibiotics Series fell 18.3% to $181.18 million.
  Stock Performance Chart for CSPC Pharmaceutical Group Ltd - ADR
  Stock Data: Recent Stock Performance:
  Current Price (11/22/2017): 104.77
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks 101.5%  
CSPC Pharmaceutical Group Ltd - ADR Key Data:
  Ticker: CHPTY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,593,627,242
(Year Ending Jan 2017).
Employees: 10,529
  Currency: U.S. Dollars Market Cap: 13,081,620,762
  Fiscal Yr Ends: December Shares Outstanding: 124,860,368
  Share Type: Ordinary Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.